Beta-adrenergic blocker withdrawal syndromes in hypertension and other cardiovascular diseases

American Heart Journal

Volumn 116, Issue 2 PART 1, 1988, Pages 515-523

  Houston, Mark C ^a   Hodge, Roger ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRENOLOL; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL; METOPROLOL TARTRATE; OXPRENOLOL; PINDOLOL; PROPRANOLOL; TIMOLOL MALEATE;

CARDIOVASCULAR DISEASE; CASE REPORT; DRUG WITHDRAWAL; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; REVIEW; WITHDRAWAL SYNDROME;

ADRENERGIC BETA-ANTAGONISTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CASE REPORT; HUMAN; HYPERTENSION; MALE; MIDDLE AGE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0023784286     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/0002-8703(88)90627-8     Document Type: Article

References (55)

1. The abrupt discontinuation of antihypertensive treatment
2. Withdrawal of antihypertensive therapy: physiological effects and therapeutic precautions
3. Adverse effects of sudden withdrawal of antihypertensive medication
4. Adverse effects of sudden withdrawal of antihypertensive medication
5. Adverse effects of sudden withdrawal of antihypertensive medication
6. Withdrawal syndromes and the cessation of antihypertensive therapy
7. Cardiovascular drug withdrawal syndromes. A potential problem with calcium antagonists?
8. Discontinuation syndrome following cessation of treatment with clonidine and other antihypertensive agents
9. Abrupt cessation of treatment in hypertension: consideration of clinical features, mechanisms, prevention and management of the discontinuation syndrome
10. Comparison of guanfacine versus clonidine for efficacy safety and occurrence of withdrawal syndrome in step-2 treatment of mild to moderate essential hypertension
11. Comparison of withdrawal phenomena after propranolol, metoprolol and pindolol
12. Myocardial infarction after propranolol withdrawal
13. Prevention of beta blocker withdrawal syndromes
14. Blood pressure and heart rate and withdrawal of antihypertensive drugs
15. Propranolol and polythiazide in treatment of hypertension
16. Comparison of metoprolol and hydrochlorthiazide as antihypertensive agents
17. Coronary artery syndromes after sudden propranolol withdrawal
18. Propranolol in angina pectoris
19. Propranolol-withdrawal rebound phenomenon. Exaceibation of coronary events after abrupt cessation of antianginal therapy
20. Withdrawal of propranolol and myocardial infarction
21. Withdrawal of propranolol and myocardial infarction
22. Withdrawal of propranolol and myocardial infarction
23. Abrupt propranolol withdrawal in angina pectoris: effects on platelet aggregation and exercise tolerance
24. Beta-blockade withdrawal
25. Propranolol withdrawal in angina pectoris: a prospective study
26. Increased density of beta-adrenergic receptors on lymphocytes following propranolol treatment
27. Withdrawal of antihypertensive therapy. Hypertensive crisis in renovascular hypertension
28. Hyperthyroidism after propranolol withdrawal
29. Acute coronary syndromes following abrupt cessation of oral propranol therapy
30. Trasicor in angina pectoris: a double-blind trial
31. Propranolol rebound—a retrospective study
32. Beta-blocker withdrawal syndrome?
33. Beta-blocker withdrawal syndrome
34. Beta-blocker withdrawal syndrome
35. Preventing propranolol withdrawal symptoms
36. Propranolol withdrawal: cause of post-coronary bypass arrhythmias and hypertension?
37. Propranolol withdrawal in the pathogenesis of hypertension following coronary artery bypass surgery
38. Noncardiac surgery in patients receiving propranolol. Case reports and recommended approach
39. Propranolol withdrawal syndrome—why?
40. Propranolol withdrawal and thyroid hormones in patients with essential hypertension
41. Mechanism of propranolol withdrawal phenomena
42. Propranolol withdrawal
43. Abrupt propranolol withdrawal and myocardial contractility. A study of effects in normal man
44. Propranolol's proposed dual antihypertensive activity
45. Plasma renin activity suppression: duration after withdrawal from beta-adrenergic blockade
46. Beta-blocker withdrawal syndrome
47. Mechanisms of supersensitivity and subsensitivity to sympathomimetic amines
48. Hypersensitivity to adrenergic stimulation after propranolol withdrawal in normal subjects
49. In vitro study of beta-adrenergic receptors
50. Elevated beta-adrenergic receptor number after chronic propranolol treatment
51. Adrenergic responsiveness after abrupt propranolol withdrawal in normal subjects and in patients with angina pectoris
52. Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol
53. Failure of gradual withdrawal of propranolol to prevent beta adrenergic supersensitivity
54. Prevention of propranolol withdrawal phenomena by gradual dose reduction
55. Persistence of biologic activity after disappearance of propranolol from the serum